Eye disease biotech raises $46.9M in Series B; Journey Medical Corporation shells out $20M upfront for dermatology franchise
ONL Therapeutics — an Ann Arbor, MI biotech that got its initial backing from Novartis in a 2017 Series A for its lead candidate Fas …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
